Market Overview

ISI Group Downgrades Bruker To Neutral

Share:
Related BRKR
Bruker Corp Has 'Great Story,' But It's Not Time To Jump In Yet
Bruker Introduces MALDI Tissuetyper Solution With New High Speed RapifleX MALDI-TOF MS System For Anatomical Pathology Research
Bruker (BRKR) Frank H. Laukien on Q4 2015 Results - Earnings Call Transcript (Seeking Alpha)

Analysts at ISI Group downgraded Bruker (NASDAQ: BRKR) from “buy” to “neutral.”

Bruker shares have surged 44.61% over the past 52 weeks, while the S&P 500 index has gained 19.69% in the same period.

Bruker's shares fell 2.20% to close at $24.02 yesterday.

Latest Ratings for BRKR

DateFirmActionFromTo
Feb 2016Deutsche BankMaintainsHold
Jan 2016Cantor FitzgeraldUpgradesHoldBuy
Jan 2016Deutsche BankInitiates Coverage onHold

View More Analyst Ratings for BRKR
View the Latest Analyst Ratings

Posted-In: ISI GroupDowngrades Analyst Ratings

 

Related Articles (BRKR)

Get Benzinga's Newsletters